CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Clal Biotechnology Industries Limited Company Snapshot
Clal Biotechnology Industries Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clal Biotechnology Industries Limited with three other miscellaneous service companies in Middle East: Kadimastem Ltd (2016 sales of 1.70 million Israel Shekels [US$487,126.12 ] ), Redhill Biopharma Ltd (386,233.09 Israel Shekels [US$110,478.11 ] ), and Evogene Limited (25.01 million Israel Shekels [US$7.15 million] of which 100% was Agricultural Crops).

Sales Analysis. Clal Biotechnology Industries Limited reported sales of 25.01 million Israel Shekels (US$7.15 million) for the year ending December of 2016. This represents a decrease of 21.3% versus 2015, when the company's sales were 31.77 million Israel Shekels. Contributing to the drop in overall sales was the 80.4% decline in Gmida Sal, from 18.62 million Israel Shekels to 3.65 million Israel Shekels. There were also decreases in sales in Kayortech (down 25.6% to 16.89 million Israel Shekels) and Other (down 79.5% to 6.11 million Israel Shekels) . However, these declines were partially offset by the increase in sales of Medivned (up 86.9% to 14.79 million Israel Shekels) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Clal Biotechnology Industries Limited
  Stock Performance Chart for Clal Biotechnology Industries Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (10/10/2017): 3.31
(Figures in Israel Shekels)
1 Week -0.4%   13 Weeks 5.2%  
4 Weeks -15.1%   52 Weeks 10.3%  
 
Clal Biotechnology Industries Limited Key Data:
  Ticker: CBI Country: Israel
  Exchanges: TEL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 25,005,000
(Year Ending Jan 2017).
Employees: 151
  Currency: Israel Shekels Market Cap: 518,164,699
  Fiscal Yr Ends: December Shares Outstanding: 156,450,694
  Share Type: Ordinary Closely Held Shares: 94,964,997
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.